that limb salvage had no adverse effect on the long-term survival of patients.
Introduction
The principal goal in the management of patients who have a primary bone sarcoma is prolonging their survival. Primary bone sarcomas that require surgical resection can be treated by either amputation or limb salvage. Most studies comparing limb salvage and amputation reported surgery, and the use of reconstructive modalities (eg, joint fusion and rotationplasty) that do not require functioning muscles after wide surgical resections.
This study evaluates the oncologic outcomes of limb salvage procedures that were used for 31 patients with primary bone sarcoma complicated by a pathologic fracture.
Materials and Methods
Our study included 31 patients (17 men and 14 women) with an average age of 17 years (range 6 to 61 years). All participants had primary bone tumors complicated by a pathologic fracture. The diagnoses were osteosarcoma (17 patients), Ewing's sarcoma (10), malignant fibrous histiocytoma (3), and lymphoma (1) . The patients were staged by local radiography, magnetic resonance imaging (MRI), computed tomography of the chest, and technetium bone scan. All of the tumors were stage IIB according to the system proposed by Enneking et al. 5 Patients who were metastatic (stage III) at presentation were not included in this study. The distal femur was affected in 13 patients, the proximal femur in 7 patients, the mid shaft femur in 3 patients, the proximal humerus in 4 patients, the proximal tibia in 3 patients and the fibula in 1 patient (Table 1) .
Fractures were present at the time of diagnosis and before the beginning of chemotherapy in 24 patients, whereas fractures occurred during preoperative chemotherapy in 7 patients. Until the time of surgery, all the fractures were managed at the time of occurrence by a plaster slab, a cast, or a Thomas splint, depending on the site of fracture. Pathologic fractures were divided into two groups -displaced (16 patients) and undisplaced (15 patients). Displaced fractures included major displacement, comminuted, segmental, washed out, and intercondylar fractures (Fig 1) . Undisplaced fractures included cracks and minimally displaced fractures.
All patients received preoperative chemotherapy during which the pathologic fractures consolidated. Drugs included 4 cycles of doxorubicin and cisplatin. In 26 patients, the fractures were solidly united both clinically and radiologically prior to surgery. In the remaining 5 patients, the fractures were not united radiologically, but clinically there was no gross abnormal mobility at the fracture site. Limb salvage was then performed and a wide resection margin was achieved in all 31 patients. Reconstruction techniques were divided into three groups. In the first group, the adjacent joint was arthrodesed and included reconstruction by a free vascularized fibular graft (8 patients), pedicled fibular graft (4), and a pedicled scapular crest graft (3). In the second group, 7 patients underwent rotationplasty. In the third group, the function of the adjacent joint was preserved and included reconstruction by a modular prosthesis (6 patients) and an osteoarticular allograft (2 patients). No reconstruction was done for the patient who had fibular resection. All of the patients who had displaced fractures had their tumor resected by an "extended wide margin" and hence fell in the first or second group. An extended wide margin is a term we devised to define a margin that is larger than the regular wide margin but less than the radical margin. The dissection is done subfascially, and all the muscles in the compartment are resected with the tumor. The muscles are cut at the level on the bone osteotomy, and an extraarticular type of resection is done to include the adjacent joint with the specimen (Fig 2) . None of the patients in this study received preoperative or postoperative radiotherapy.
Patients were examined clinically and radiologically every 6 weeks during the first 6 months, then every 3 months for the following 2 years, then every 6 months for 3 years, and then annually thereafter. Computed tomography scans of the chest were taken every 3 months in the first year, every 6 months in the second year, and then annually for 5 years. A bone scan was done every 6 months in the first year, then annually for 2 years.
Results
The mean follow-up period in this study was 18 months, ranging from 8 to 51 months. Two patients had local recurrence, one at 5 months and one at 12 months. They were managed by amputation but eventually died of metastatic (2) 1 (50%) 1 (50%) Wide resection only (1) --Total (31) 2 (6%) 6 (19%) disease, one at 8 months and one at 18 months following the original limb-sparing surgery. Pulmonary metastases occurred in 6 patients; 3 underwent lung metastasectomy, but all 6 ultimately died of metastatic disease. We attempted to correlate the incidence of local recurrence and pulmonary metastases to the type of tumor, type of fracture, and type of surgery (Table 2 ).
Discussion
Several questions arise when developing a treatment strategy for patients who have a primary bone tumor that is complicated by a pathologic fracture: Is the presence of a pathologic fracture in a primary bone sarcoma a poor prognostic factor that mandates immediate amputation? Is the rate of local recurrence higher with limb salvage than with amputation? Is the oncologic outcome affected by the type, time, and outcome of the pathologic fracture or by the type of tumor or reconstruction? We attempted to answer these questions in this study. Although the results were not statistically significant due to small numbers, they suggest certain trends. This study may also serve as a source of data for future meta-analysis that can guide us in choosing the optimal management strategy for patients with pathologic fractures of primary bone tumors.
Glasser et al 6 reported that the occurrence of a pathologic fracture in a primary bone tumor was associated with an impaired survival rate. The fracture probably denoted the aggressive nature of the tumor that ultimately caused the bone to fracture. 6 However, the survival of the patients with pathologic fractures of the primary bone tumors who underwent limb salvage was similar to those who had an amputation. The incidence of pulmonary metastases in our series was 19.3%. This is less than the 23% incidence rate reported by Scully et al, 7 but this may be due to our short follow-up period. When we compared the incidence of metastases in osteosarcoma patients in this series with a similar group of patients who did not sustain a pathologic fracture and were followed for the same period of time at our institution, we found that they had the same outcome (E. Safwan, MD, unpublished data, 2001). The local recurrence rate in our series was 6.5%, which is less than the 23% rate reported by Scully et al 7 and the 19% rate reported by Abudu et al. 3 However, most of the patients in the latter study had contaminated margins of tumor resection. Although the low incidence of local recurrence in our series may be attributed to the short follow-up period, we believe it resulted from our the use of extended wide margins of resection for all displaced fractures. Of the 22 patients in our study who had an extended wide margin of resection and reconstruction by rotationplasty or joint fusion, only 1 developed local recurrence. Joint fusion results in a functional outcome that is inferior to a mobile (Figs 3 and 4) , which is similar to the 84% incidence rate reported by Jaffe et al. 8 Also, fracture union correlated with a high tumor necrosis percentage, thus indicating a good response to chemotherapy. 9 Tumors that are not sensitive to chemotherapy (eg, chondrosarcoma) may not be amenable to limb salvage if fractures have occurred. These types of tumors were not included in our study.
Two patients with local recurrence had displaced fractures that occurred before the beginning of chemotherapy. However, Scully et al 7 stated that neither the type nor the timing of the pathologic fractures affects the oncologic outcome.
Conclusions
Pathologic fractures of primary bone sarcoma should not be considered an absolute indication for amputation. Patients should be treated by neoadjuvant chemotherapy, and their tumors should then be resected with adequate margins that might entail performing an extended wide margin in some cases. In doing so, the oncologic outcome of these patients will probably not be jeopardized.
Studies reported in the literature describing the management of pathologic fractures of primary bone tumors are limited and include only small numbers of patients. Multi-institutional studies are needed to obtain statistically significant data that will assist in treating this patient population. A B
